Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology.

Yan G, Li L, Tao Y, Liu S, Liu Y, Luo W, Wu Y, Tang M, Dong Z, Cao Y.

Proteomics. 2006 Mar;6(6):1810-21.

PMID:
16470631
2.

Functional proteomics to identify critical proteins in signal transduction pathways.

Yan GR, He QY.

Amino Acids. 2008 Aug;35(2):267-74. Epub 2007 Aug 17. Review.

PMID:
17704892
3.
4.

Epstein-Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway.

Yan G, Luo W, Lu Z, Luo X, Li L, Liu S, Liu Y, Tang M, Dong Z, Cao Y.

Cell Signal. 2007 Feb;19(2):341-8. Epub 2006 Aug 3.

PMID:
16989986
5.

Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.

Liu YP, Tan YN, Wang ZL, Zeng L, Lu ZX, Li LL, Luo W, Tang M, Cao Y.

Int J Mol Med. 2008 Feb;21(2):153-62.

PMID:
18204781
6.

Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.

Song X, Tao YG, Deng XY, Jin X, Tan YN, Tang M, Wu Q, Lee LM, Cao Y.

Cell Signal. 2004 Oct;16(10):1153-62.

PMID:
15240010
7.

Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.

Zheng H, Li LL, Hu DS, Deng XY, Cao Y.

Cell Mol Immunol. 2007 Jun;4(3):185-96. Review.

8.

Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology.

Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T, Schulenberg B, Hendrickson J, Beechem JM, Haugland RP, Patton WF.

Proteomics. 2003 Jul;3(7):1128-44.

PMID:
12872214
9.

Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.

Lin X, Tang M, Tao Y, Li L, Liu S, Guo L, Li Z, Ma X, Xu J, Cao Y.

Cancer Sci. 2012 Jun;103(6):993-9. doi: 10.1111/j.1349-7006.2012.02271.x. Epub 2012 Apr 30.

10.

The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.

Dawson CW, George JH, Blake SM, Longnecker R, Young LS.

Virology. 2001 Oct 25;289(2):192-207.

11.
12.

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.

Terrin L, Dal Col J, Rampazzo E, Zancai P, Pedrotti M, Ammirabile G, Bergamin S, Rizzo S, Dolcetti R, De Rossi A.

J Virol. 2008 Oct;82(20):10175-87. doi: 10.1128/JVI.00321-08. Epub 2008 Aug 6.

13.

Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.

Zhang X, Sanmun D, Hu L, Fadeel B, Ernberg I.

Biochem Biophys Res Commun. 2007 Aug 17;360(1):263-8. Epub 2007 Jun 18.

PMID:
17586463
14.

Mechanism of action of a novel latent membrane protein-1 dominant negative.

Brennan P, Floettmann JE, Mehl A, Jones M, Rowe M.

J Biol Chem. 2001 Jan 12;276(2):1195-203.

15.
16.

In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.

Pioche-Durieu C, Keryer C, Souquère S, Bosq J, Faigle W, Loew D, Hirashima M, Nishi N, Middeldorp J, Busson P.

J Virol. 2005 Nov;79(21):13326-37.

17.

Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways.

Yan GR, Xiao CL, He GW, Yin XF, Chen NP, Cao Y, He QY.

Proteomics. 2010 Mar;10(5):976-86. doi: 10.1002/pmic.200900662.

PMID:
20049867
18.

Epstein-Barr virus latent membrane protein 1 mediates serine 25 phosphorylation and nuclear entry of annexin A2 via PI-PLC-PKCalpha/PKCbeta pathway.

Luo W, Yan G, Li L, Wang Z, Liu H, Zhou S, Liu S, Tang M, Yi W, Dong Z, Cao Y.

Mol Carcinog. 2008 Dec;47(12):934-46. doi: 10.1002/mc.20445.

PMID:
18412141
19.
20.

STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling.

Wang Z, Luo F, Li L, Yang L, Hu D, Ma X, Lu Z, Sun L, Cao Y.

Eur J Cancer. 2010 Nov;46(16):2996-3006. doi: 10.1016/j.ejca.2010.07.008. Epub 2010 Aug 13.

PMID:
20709526

Supplemental Content

Support Center